Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021
View/ Open
Publisher version (Check access options)
Check access options
Date
2024Author
Rajagopal Padma, M.Dinesh, Prameela
Sundaresan, Rajesh
Athreya, Siva
Shiju, Shilpa
Maroor, Parimala S.
Lalitha Hande, R.
Akhtar, Jawaid
Chandra, Trilok
Ravi, Deepa
Lobo, Eunice
Ana, Yamuna
Shriyan, Prafulla
Desai, Anita
Rangaiah, Ambica
Munivenkatappa, Ashok
Krishna, S.
Basawarajappa, Shantala Gowdara
Sreedhara, H.G.
Siddesh, K.C.
Kumari, B. Amrutha
Umar, Nawaz
Mythri, B.A.
Mythri, K.M.
Sudarshan, Mysore Kalappa
Vasanthapuram, Ravi
Rathnaiah Babu, Giridhara
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Objective
Demonstrate the feasibility of using the existing sentinel surveillance infrastructure to conduct the second round of the serial cross-sectional sentinel-based population survey. Assess active infection, seroprevalence, and their evolution in the general population across Karnataka. Identify local variations for locally appropriate actions. Additionally, assess the clinical sensitivity of the testing kit used on account of variability of antibody levels in the population.
Methods
The cross-sectional study of 41,228 participants across 290 healthcare facilities in all 30 districts of Karnataka was done among three groups of participants (low, moderate, and high-risk). The geographical spread was sufficient to capture local variations. Consenting participants were subjected to real-time reverse transcription-polymerase chain reaction (RT-PCR) testing, and antibody (IgG) testing. Clinical sensitivity was assessed by conducting a longitudinal study among participants identified as COVID-19 positive in the first survey round.
Results
Overall weighted adjusted seroprevalence of IgG was 15.6% (95% CI: 14.9–16.3), crude IgG prevalence was 15.0% and crude active infection was 0.5%. Statewide infection fatality rate (IFR) was estimated as 0.11%, and COVID-19 burden estimated between 26.1 to 37.7% (at 90% confidence). Further, Cases-to-infections ratio (CIR) varied 3-35 across units and IFR varied 0.04–0.50% across units. Clinical sensitivity of the IgG ELISA test kit was estimated as ≥38.9%.
Conclusion
We demonstrated the feasibility and simplicity of sentinel-based population survey in measuring variations in subnational and local data, useful for locally appropriate actions in different locations. The sentinel-based population survey thus helped identify districts that needed better testing, reporting, and clinical management. The state was far from attaining natural immunity during the survey and hence must step up vaccination coverage and enforce public health measures to prevent the spread of COVD-19.
Collections
- COVID-19 Research [835 items ]
- Medicine Research [1508 items ]